Clinical Trial Results:
CHANT (Cerebral Hemorrhage And NXY Treatment)
A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase IIb study to assess the safety and tolerability of 72 hours intravenous infusion of NXY 059 in adult patients with acute intracerebral hemorrhage (ICH)
Summary
|
|
EudraCT number |
2004-000566-12 |
Trial protocol |
SE |
Global completion date |
19 Jan 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
31 Dec 2016
|
First version publication date |
31 Dec 2016
|
Other versions |
|
Summary report(s) |
SA-NXY-0012_2004-000566-12 Study Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.